← Back

Wire · regulatory

AHA Responds to FDA Request for Input on Development of 21st Century Cures Act Section ...

Published

13 August 2026

Topic

regulatory

Sectors

Healthtech Infrastructure

Geography

United States

Source

Read at aha.org

Verified

Fusion42 · 13 August 2026 · Fusion42 review

The American Hospital Association (AHA) provided input to the FDA on Section 3060 of the 21st Century Cures Act, urging permanent adoption of enforcement discretion for single clinical recommendation decision support software and clarifications on general wellness product guidance to ensure patient safety amid evolving digital health technologies.

This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure.

◆ The Wire takeaway

You face a changing regulatory path for clinical decision support software that can ease product development and market entry now that the FDA may permanently relax rules on single recommendation tools. Clarify your product claims and patient safety messaging in wellness tech to stay ahead of evolving FDA guidelines.

Coverage

1 source · 13 Aug 2026

Related on Wire

Topics

Healthtech Infrastructure21st-century-cures-actclinical-decision-supportgeneral-wellness-guidancedigital-healthFDA-regulation